The Tumor Microenvironment in Colorectal Cancer Therapy

The current standard-of-care for metastatic colorectal cancer (mCRC) includes chemotherapy and anti-angiogenic or anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, even though the addition of anti-angiogenic agents to backbone chemotherapy provides little benefit for overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedrosa, Leire, Esposito, Francis, Thomson, Timothy M., Maurel, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721633/
https://www.ncbi.nlm.nih.gov/pubmed/31416205
http://dx.doi.org/10.3390/cancers11081172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721633/
https://www.ncbi.nlm.nih.gov/pubmed/31416205
http://dx.doi.org/10.3390/cancers11081172

Ejemplares similares